Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01625637 · ClinicalTrials.gov registry record · Phase 2
Tobacco Approach Avoidance Training for Adolescent Smokers-2
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT01625637 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 66 participants.
The verdict
NCT01625637, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is a two part study. In Study 2, smokers who want to quit smoking will participate in a 4 week smoking cessation program combining weekly cognitive behavioral therapy (CBT) with weekly regular-AAT or placebo-AAT training. We hypothesize that adolescent smokers will exhibit stronger approach tendencies towards smoking-related stimuli in the tobacco Approach Avoidance Training (AAT) task when compared with nonsmokers and that adolescent smokers who are trained to avoid smoking related stimuli using the AAT will avoid tobacco approach tendencies in the AAT test trials and the Implicit Association Task, when compared to adolescent smokers who are not exposed to AAT training. We also hypothesize that adolescent smokers who are trained to avoid tobacco in a training AAT in combination with CBT will have better abstinence rates compared to those who receive placebo AAT training with CBT.
Interventions
- BEHAVIORAL AAT-experiment
- BEHAVIORAL AAT-placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01625637
The ClinicalTrials.gov registry entry for NCT01625637 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AAT-experiment is the first listed.
NCT01625637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01625637 about?
NCT01625637 is a clinical study titled "Tobacco Approach Avoidance Training for Adolescent Smokers-2". This is a two part study. In Study 2, smokers who want to quit smoking will participate in a 4 week smoking cessation program combining weekly cognitive behavioral therapy (CBT) with weekly regular-AAT or placebo-AAT training. We hypothesize that adolescent smokers will exhibit stronger approach ten...
What is the current status of trial NCT01625637?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2012-05. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01625637?
The interventions under investigation include: AAT-experiment (BEHAVIORAL), AAT-placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT01625637?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.